Jeil Pharmaceutical Co Ltd (271980) — Cash Flow Reinvestment Rate
Jeil Pharmaceutical Co Ltd (271980) has a Cash Flow Reinvestment Rate of 0.81x as of September 2025, reinvesting ₩10.66 Billion (capex ₩3.55 Billion plus investments ₩-7.11 Billion) from operating cash flow of ₩13.23 Billion. Explore Jeil Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jeil Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Jeil Pharmaceutical Co Ltd across 4 annual periods. Also explore Jeil Pharmaceutical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jeil Pharmaceutical Co Ltd (2018–2024)
Year-by-year capital reinvestment analysis for Jeil Pharmaceutical Co Ltd. For live market cap and broader valuation context, see how much is Jeil Pharmaceutical Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.47x | ₩7.93 Billion | ₩3.21 Billion | ₩6.61 Billion | ▲ +661.2% |
| 2021 | 0.32x | ₩6.19 Billion | ₩19.10 Billion | ₩5.34 Billion | ▲ +638.5% |
| 2019 | 0.04x | ₩1.27 Billion | ₩28.96 Billion | ₩1.09 Billion | ▼ -95.5% |
| 2018 | 0.96x | ₩20.69 Billion | ₩21.45 Billion | ₩10.29 Billion | — |